Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study protocol documentation on the page updated its revision tag to v3.6.4, replacing the previous v3.6.3, indicating a newer version of the documented materials is now referenced.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small update to the page's metadata/template. No study content, eligibility criteria, or results are impacted.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer build of the site. No changes to the study content or page text are described in the provided data.SummaryDifference0.0%

- Check54 days agoChange DetectedRecruitment status updated to indicate enrollment has ended, and new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added along with a revised footer label (Revision: v3.6.0); the Intervention/Treatment heading formatting is standardized by removing the spaced slash.SummaryDifference0.3%

- Check61 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor revision to the page content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision label has been updated from v3.5.3 to v3.5.4. This represents a new release of the page's content/code, without modifying displayed study details.SummaryDifference0.0%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.